LISBON, PORTUGAL — In the evolving landscape of psychiatry, where diagnoses often rest on symptomatic descriptions rather than definitive causes, Gonçalo Cotovio, MD, PhD, is pioneering a bold approach that seeks to untangle the web of brain networks underlying mental illness. At the Champalimaud Foundation in Lisbon, Cotovio’s work transcends traditional paradigms by focusing on causality rather than correlation, employing innovative techniques such as lesion network mapping to chart the precise circuits in the brain responsible for complex psychiatric symptoms.
The core of Cotovio’s approach stems from a simple yet transformative premise: specific, localized brain lesions can induce syndrome-like manic states or obsessive-compulsive behaviors in previously healthy individuals. This observation disrupts decades of psychiatry’s associative model, suggesting that these focal disruptions illuminate not just the presence of pathological activity but the actual mechanistic circuitry responsible for psychiatric symptoms. Lesion network mapping extends this understanding by using resting-state functional connectivity data to map the connected networks of these small injury sites, revealing shared brain circuits linked to particular psychiatric phenotypes across patients.
Such a methodology offers a powerful lens to dissect psychiatric disorders, which traditionally have suffered from heterogeneity and a lack of mechanistic clarity. Cotovio’s investigations into mania and lesional obsessive-compulsive disorder exemplify how disparate symptoms, when examined through lesion networks, converge on common circuit pathways, paving the way to conceptualize psychiatric diagnoses around dynamic networks rather than static brain regions. This network-based conceptualization challenges old models and opens therapeutic avenues previously inaccessible.
Crucially, Cotovio’s research moves beyond mapping. It segues into personalized neuromodulation, leveraging cutting-edge MRI techniques that enable transcranial magnetic stimulation (TMS) to be precisely targeted. By integrating each individual’s unique brain connectivity profile, his team pioneers bespoke stimulation protocols designed to modulate the causal circuits identified through lesion mapping. This individualized approach stands in stark contrast to the conventional one-size-fits-all neuromodulation methods, representing a new frontier in translational psychiatry where treatment is informed directly by mechanistic neurobiology.
Under the expert guidance of Albino J. Oliveira-Maia and through collaborative experiences with luminaries such as Alvaro Pascual-Leone, Michael D. Fox, and Daniel Press at Harvard Medical School, Cotovio has honed a multidisciplinary skill set. He seamlessly navigates the interface between clinical psychiatry, advanced neuroimaging, and basic neuroscience. This integrative perspective is vital, enabling a bidirectional flow of insights from bedside to bench and back, ensuring that novel hypotheses generated from human clinical observations are rigorously tested and refined through neuroscience techniques.
The potential implications of defining causal circuits involved in psychiatric symptoms are profound. Once reliable circuits are established, they can function as biomarkers for brain state and treatment responses. Cotovio is investigating cortical excitability and functional connectivity patterns as candidate markers that could guide clinical decisions regarding who might benefit most from tailored neuromodulation treatments. Such biomarkers embody a key step toward precision psychiatry, promising to reduce the trial-and-error prescribing that characterizes much of current psychiatric care.
Despite these promising advances, Cotovio stresses scientific humility and caution. The complexities of neuropsychiatric disorders demand patience, iterative testing, and constant reevaluation of assumptions. His dictum to couple focus and calmness with persistence underlines a scientific ethos oriented toward responsible innovation rather than premature claims. He insists that the ultimate measure of research validity must be its capacity to alleviate human suffering and improve lives, an ethical imperative often absent in purely mechanistic neuroscientific pursuits.
This research trajectory, deeply rooted in clinical observation and mechanistic inquiry, challenges the reductionist stereotype often associated with neuroscience. Cotovio’s work demonstrates that mechanistic understanding need not negate the multifaceted nature of psychiatric disorders encompassing emotional, behavioral, and social dimensions. On the contrary, elucidating causal circuits provides a foundation upon which nuanced, holistic therapeutics can be developed—therapies that respect the individual complexity of mental illness while targeting underlying pathophysiology.
Personal facets also punctuate Cotovio’s professional journey. Born into a family where dinner conversations revolved around the intricacies of psychiatric illness and human emotion, his passion was seeded early. He credits his father, a psychiatrist, as both a personal and professional inspiration. Outside the lab and clinic, he finds mental clarity and balance through running and values quiet, reflective moments with family—habits that reinforce his philosophy of maintaining equilibrium amid the demands of translational research.
As Cotovio’s work continues to unfold, it posits a compelling argument for psychiatry’s future: that it can evolve into a mechanistic discipline deeply anchored in human biology without sacrificing the richness of individual experience. It maintains that cutting-edge neuromodulatory interventions, precisely targeted by causal maps of brain networks, may offer more transformative results than symptom-driven pharmacotherapy or psychotherapy alone. Though still in its infancy, this approach reflects a decisive step toward unraveling mental illness at a fundamental neural level.
His Genomic Press interview, available openly in Brain Medicine, offers further insight into his pioneering vision and methodology. It serves as both a roadmap and an invitation for the psychiatric and neuroscience communities to embrace models that fuse computational precision, clinical relevance, and ethical responsibility. Cotovio’s work exemplifies the kind of scientific leadership that is essential to transform mental health care, harnessing the synergy of cutting-edge technology and humanistic values.
In an era hungry for breakthroughs in psychiatric medicine, Gonçalo Cotovio’s integrative framework offers not just hope but a tangible strategy to reshape how brain disorders are understood and treated. By mapping the true causal circuitry behind devastating symptoms and moving rapidly to individualized neuromodulation, his research promises a paradigm shift—a scientific bet on causality that could redefine psychiatry’s scope and impact in the decades to come.
Subject of Research: People
Article Title: Gonçalo Cotovio: Mapping causal brain circuits to personalize neuromodulation in psychiatry
News Publication Date: 5 May 2026
Web References:
https://doi.org/10.61373/bm026k.0033
https://interviews.genomicpress.com/
Image Credits: Gonçalo Cotovio, MD, PhD, Champalimaud Foundation, Portugal
Keywords: lesion network mapping, psychiatry, neuromodulation, transcranial magnetic stimulation, brain circuits, causal mechanisms, obsessive-compulsive disorder, mania, precision psychiatry, functional connectivity, biomarkers, translational neuroscience
